A Study of Balapiravir in Patients With Dengue Virus Infection

NCT01096576 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Dengue

Interventions

DRUG: balapiravir [RO4588161]
DRUG: placebo

Sponsor

Hoffmann-La Roche